ID   SIK3_HUMAN              Reviewed;        1263 AA.
AC   Q9Y2K2; A1A5A8; Q59FY2; Q5M9N1; Q6P3R6; Q8IYM8; Q9HA50;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=Serine/threonine-protein kinase SIK3;
DE            EC=2.7.11.1;
DE   AltName: Full=Salt-inducible kinase 3;
DE            Short=SIK-3;
DE   AltName: Full=Serine/threonine-protein kinase QSK;
GN   Name=SIK3; Synonyms=KIAA0999, QSK; ORFNames=L19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-163, AND MUTAGENESIS OF THR-163.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 667-1129 (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 758-1263.
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 273-1263, AND VARIANT
RP   ARG-1078.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 758-1263.
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 758-1263.
RX   PubMed=15334068; DOI=10.1038/sj.onc.1207921;
RA   Petroziello J., Yamane A., Westendorf L., Thompson M., McDonagh C.,
RA   Cerveny C., Law C.-L., Wahl A., Carter P.;
RT   "Suppression subtractive hybridization and expression profiling
RT   identifies a unique set of genes overexpressed in non-small-cell lung
RT   cancer.";
RL   Oncogene 23:7734-7745(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH YWHAZ.
RX   PubMed=16306228; DOI=10.1242/jcs.02670;
RA   Al-Hakim A.K., Goransson O., Deak M., Toth R., Campbell D.G.,
RA   Morrice N.A., Prescott A.R., Alessi D.R.;
RT   "14-3-3 cooperates with LKB1 to regulate the activity and localization
RT   of QSK and SIK.";
RL   J. Cell Sci. 118:5661-5673(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; THR-163; SER-493;
RP   SER-568 AND SER-808, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-70 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-163; THR-411; SER-493;
RP   SER-568 AND SER-808, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-411; SER-568 AND
RP   SER-920, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-331 AND VAL-1103.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-163.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds to and is activated by YWHAZ when phosphorylated on
CC       Thr-163.
CC   -!- INTERACTION:
CC       Q13077:TRAF1; NbExp=3; IntAct=EBI-10326390, EBI-359224;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-10326390, EBI-742327;
CC       P63104:YWHAZ; NbExp=5; IntAct=EBI-1181460, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16306228}.
CC       Note=Locates to punctate structures within the cytoplasm on
CC       binding to YWHAZ.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y2K2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2K2-2; Sequence=VSP_020889, VSP_020890, VSP_020891;
CC         Note=No experimental confirmation available. Contains a
CC         phosphothreonine at position 70. {ECO:0000244|PubMed:19690332};
CC       Name=3;
CC         IsoId=Q9Y2K2-3; Sequence=VSP_020892, VSP_020893;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9Y2K2-4; Sequence=VSP_054135, VSP_054136, VSP_054137;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated at Thr-163 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39.
CC       {ECO:0000269|PubMed:14976552}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAT06749.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA76843.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB14006.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023216; BAA76843.2; ALT_INIT; mRNA.
DR   EMBL; AP000936; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003070; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP006216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC035583; AAH35583.3; -; mRNA.
DR   EMBL; BC063887; AAH63887.1; -; mRNA.
DR   EMBL; BC086858; AAH86858.1; -; mRNA.
DR   EMBL; BC128510; AAI28511.1; -; mRNA.
DR   EMBL; AB209327; BAD92564.1; -; mRNA.
DR   EMBL; AK022302; BAB14006.1; ALT_INIT; mRNA.
DR   EMBL; AY598338; AAT06749.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001268678.1; NM_001281749.1.
DR   RefSeq; NP_079440.3; NM_025164.4.
DR   UniGene; Hs.167451; -.
DR   ProteinModelPortal; Q9Y2K2; -.
DR   SMR; Q9Y2K2; -.
DR   BioGrid; 116963; 19.
DR   IntAct; Q9Y2K2; 11.
DR   STRING; 9606.ENSP00000292055; -.
DR   BindingDB; Q9Y2K2; -.
DR   ChEMBL; CHEMBL6149; -.
DR   GuidetoPHARMACOLOGY; 2199; -.
DR   iPTMnet; Q9Y2K2; -.
DR   PhosphoSitePlus; Q9Y2K2; -.
DR   BioMuta; SIK3; -.
DR   DMDM; 115502238; -.
DR   EPD; Q9Y2K2; -.
DR   PaxDb; Q9Y2K2; -.
DR   PeptideAtlas; Q9Y2K2; -.
DR   PRIDE; Q9Y2K2; -.
DR   DNASU; 23387; -.
DR   Ensembl; ENST00000292055; ENSP00000292055; ENSG00000160584.
DR   Ensembl; ENST00000375288; ENSP00000364437; ENSG00000160584.
DR   Ensembl; ENST00000542607; ENSP00000438108; ENSG00000160584.
DR   GeneID; 23387; -.
DR   KEGG; hsa:23387; -.
DR   CTD; 23387; -.
DR   DisGeNET; 23387; -.
DR   GeneCards; SIK3; -.
DR   H-InvDB; HIX0004310; -.
DR   HGNC; HGNC:29165; SIK3.
DR   HPA; HPA045245; -.
DR   HPA; HPA048161; -.
DR   MIM; 614776; gene.
DR   neXtProt; NX_Q9Y2K2; -.
DR   PharmGKB; PA165543631; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   eggNOG; ENOG410XNQ0; LUCA.
DR   HOGENOM; HOG000154056; -.
DR   HOVERGEN; HBG079682; -.
DR   InParanoid; Q9Y2K2; -.
DR   KO; K19009; -.
DR   PhylomeDB; Q9Y2K2; -.
DR   TreeFam; TF315213; -.
DR   SignaLink; Q9Y2K2; -.
DR   SIGNOR; Q9Y2K2; -.
DR   ChiTaRS; SIK3; human.
DR   GeneWiki; KIAA0999; -.
DR   GenomeRNAi; 23387; -.
DR   PRO; PR:Q9Y2K2; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000160584; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   CDD; cd14071; STKc_SIK; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR034672; SIK.
DR   InterPro; IPR015940; UBA.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1263       Serine/threonine-protein kinase SIK3.
FT                                /FTId=PRO_0000252257.
FT   DOMAIN        8    259       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      286    326       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   NP_BIND      14     22       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    592    958       Gln-rich.
FT   ACT_SITE    130    130       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      37     37       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      13     13       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     163    163       Phosphothreonine; by LKB1.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:14976552}.
FT   MOD_RES     411    411       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     493    493       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     533    533       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6P4S6}.
FT   MOD_RES     534    534       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6P4S6}.
FT   MOD_RES     568    568       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     589    589       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6P4S6}.
FT   MOD_RES     808    808       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     920    920       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     928    928       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q6P4S6}.
FT   VAR_SEQ       1    605       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020889.
FT   VAR_SEQ     307    354       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054135.
FT   VAR_SEQ     545    545       S -> RYLANRSKRHTLAMTNPTAEIPPDLQRQLGQQPFRS
FT                                RVWPPHLVPDQHR (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054136.
FT   VAR_SEQ     606    702       GQIDERTLEKTQQQHMLYQQEQHHQILQQQIQDSICPPQPS
FT                                PPLQAACENQPALLTHQLQRLRIQPSSPPPNHPNNHLFRQP
FT                                SNSPPPMSSAMIQPH -> MGLRASRPSKLTWKKWATTAAS
FT                                NSCSRSVSSCRRCTGGRLMKEPWRRPSSSICYTSRSSTIKF
FT                                SSNKFKTLSVLLSHLHLFRLHVKISQPSLPISSR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020890.
FT   VAR_SEQ     816    875       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054137.
FT   VAR_SEQ     817    876       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020891.
FT   VAR_SEQ    1113   1129       EPVIGNCMDRSSPGQAV -> GKCLLTVEVLGQSALIN
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020892.
FT   VAR_SEQ    1130   1263       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020893.
FT   VARIANT     331    331       H -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035634.
FT   VARIANT    1040   1040       D -> E (in dbSNP:rs11216163).
FT                                /FTId=VAR_051662.
FT   VARIANT    1078   1078       P -> R (in dbSNP:rs12225230).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_051663.
FT   VARIANT    1103   1103       A -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035635.
FT   MUTAGEN     163    163       T->A: Prevents phosphorylation and
FT                                activation by STK11/LKB1 complex.
FT                                {ECO:0000269|PubMed:14976552}.
FT   CONFLICT    488    490       LGR -> MGL (in Ref. 5; AAH63887).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1263 AA;  139980 MW;  7CE628D4DF172206 CRC64;
     MPARIGYYEI DRTIGKGNFA VVKRATHLVT KAKVAIKIID KTQLDEENLK KIFREVQIMK
     MLCHPHIIRL YQVMETERMI YLVTEYASGG EIFDHLVAHG RMAEKEARRK FKQIVTAVYF
     CHCRNIVHRD LKAENLLLDA NLNIKIADFG FSNLFTPGQL LKTWCGSPPY AAPELFEGKE
     YDGPKVDIWS LGVVLYVLVC GALPFDGSTL QNLRARVLSG KFRIPFFMST ECEHLIRHML
     VLDPNKRLSM EQICKHKWMK LGDADPNFDR LIAECQQLKE ERQVDPLNED VLLAMEDMGL
     DKEQTLQSLR SDAYDHYSAI YSLLCDRHKR HKTLRLGALP SMPRALAFQA PVNIQAEQAG
     TAMNISVPQV QLINPENQIV EPDGTLNLDS DEGEEPSPEA LVRYLSMRRH TVGVADPRTE
     VMEDLQKLLP GFPGVNPQAP FLQVAPNVNF MHNLLPMQNL QPTGQLEYKE QSLLQPPTLQ
     LLNGMGPLGR RASDGGANIQ LHAQQLLKRP RGPSPLVTMT PAVPAVTPVD EESSDGEPDQ
     EAVQSSTYKD SNTLHLPTER FSPVRRFSDG AASIQAFKAH LEKMGNNSSI KQLQQECEQL
     QKMYGGQIDE RTLEKTQQQH MLYQQEQHHQ ILQQQIQDSI CPPQPSPPLQ AACENQPALL
     THQLQRLRIQ PSSPPPNHPN NHLFRQPSNS PPPMSSAMIQ PHGAASSSQF QGLPSRSAIF
     QQQPENCSSP PNVALTCLGM QQPAQSQQVT IQVQEPVDML SNMPGTAAGS SGRGISISPS
     AGQMQMQHRT NLMATLSYGH RPLSKQLSAD SAEAHSLNVN RFSPANYDQA HLHPHLFSDQ
     SRGSPSSYSP STGVGFSPTQ ALKVPPLDQF PTFPPSAHQQ PPHYTTSALQ QALLSPTPPD
     YTRHQQVPHI LQGLLSPRHS LTGHSDIRLP PTEFAQLIKR QQQQRQQQQQ QQQQQEYQEL
     FRHMNQGDAG SLAPSLGGQS MTERQALSYQ NADSYHHHTS PQHLLQIRAQ ECVSQASSPT
     PPHGYAHQPA LMHSESMEED CSCEGAKDGF QDSKSSSTLT KGCHDSPLLL STGGPGDPES
     LLGTVSHAQE LGIHPYGHQP TAAFSKNKVP SREPVIGNCM DRSSPGQAVE LPDHNGLGYP
     ARPSVHEHHR PRALQRHHTI QNSDDAYVQL DNLPGMSLVA GKALSSARMS DAVLSQSSLM
     GSQQFQDGEN EECGASLGGH EHPDLSDGSQ HLNSSCYPST CITDILLSYK HPEVSFSMEQ
     AGV
//
